Dyskinesia, Medication-Induced
4 clinical trials · Condition
◉ Watch Dyskinesia, Medication-Induced
| Record | Firm | Date |
|---|---|---|
| AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia (NCT04147949) | VistaGen Therapeutics, Inc. | 2022-08-01 |
| Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia (NCT05297201) | Celon Pharma SA | 2021-11-02 |
| Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS) (NCT02657681) | Fundación de investigación HM | 2015-10-01 |
| Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia (NCT00175955) | UCB Pharma | 2005-05-01 |
Track Dyskinesia, Medication-Induced automatically
Every clearance here is in the API, with alerts when new ones post.